BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21896780)

  • 21. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
    Marks JL; Gong Y; Chitale D; Golas B; McLellan MD; Kasai Y; Ding L; Mardis ER; Wilson RK; Solit D; Levine R; Michel K; Thomas RK; Rusch VW; Ladanyi M; Pao W
    Cancer Res; 2008 Jul; 68(14):5524-8. PubMed ID: 18632602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells.
    Sun KK; Ji C; Li X; Zhang L; Deng J; Zhong N; Wu XY
    Mol Med Rep; 2013 May; 7(5):1678-82. PubMed ID: 23467607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.
    Ma X; Huang J; Tian Y; Chen Y; Yang Y; Zhang X; Zhang F; Xue L
    Oncogene; 2017 Jun; 36(22):3159-3167. PubMed ID: 28068320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.
    Pavese JM; Ogden IM; Voll EA; Huang X; Xu L; Jovanovic B; Bergan RC
    PLoS One; 2014; 9(7):e102289. PubMed ID: 25019290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
    Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
    Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.
    Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH
    Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
    Wu X; Gong Z; Sun L; Ma L; Wang Q
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.
    Finegan KG; Tournier C
    Cancer Res; 2010 Jul; 70(14):5797-806. PubMed ID: 20610622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogen-activated protein kinase kinase 4 (MKK4).
    Cuenda A
    Int J Biochem Cell Biol; 2000 Jun; 32(6):581-7. PubMed ID: 10785355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer.
    Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM
    Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
    Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
    Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
    Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
    Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
    Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
    Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.